MIR5787

Across TCGA pan-cancer cohorts, MIR5787 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR5787 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR5787 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR5787 expression acts as an unfavorable survival marker.

LUAD, LIHC, and READ are the cancer types where MIR5787 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	87	view →
LIHC	OS	Tertile	II,III,IV	0.051	0.772	<.001	72	view →
READ	DFS	Tertile	All	0.255	0.844	.004	63	view →
UCEC	OS	Tertile	III,IV	0.110	0.830	<.001	36	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	18	view →
MESO	DFS	Tertile	All	0.098	0.366	.039	18	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
ACC	OS	Tertile	All	0.497	0.807	.032	18	view →
PRAD	DFS	Tertile	All	0.180	0.779	<.001	18	view →
COAD	DFS	Tertile	II,III,IV	0.083	0.776	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR5787–LUAD (DFS)

Open the LUAD breakdown →